Inhibition of drug efflux by pluronics in S. cerevisiae

DSpace/Manakin Repository

Show simple item record

dc.contributor.author Diezi, Thomas
dc.contributor.author Ruggle, Brian
dc.contributor.author Pandit, Nivedita K.
dc.contributor.author Sleister, Heidi
dc.date.accessioned 2007-05-31T20:21:50Z
dc.date.available 2007-05-31T20:21:50Z
dc.date.issued 2007-05-31T20:21:50Z
dc.identifier.uri http://hdl.handle.net/2092/566
dc.description.abstract Overexpression of P-gp efflux pumps is believed to be responsible for multidrug resistance of mammalian cancer cells. Inhibition of these pumps is expected to increase the efficacy and decrease the toxicity of chemotherapeutic agents. The non-ionic triblock copolymer Pluronic P85 is reported to inhibit mammalian P-gp efflux pumps, leading to higher intracellular drug concentrations. An analogous, well-characterized efflux transporter, Pdr5p, has been identified in the yeast Saccharomyces cerevisiae, but the effect of Pluronic copolymers on this transporter has not been studied. We have examined the inhibitory effects of P85 on three strains of S. cerevisiae: a pdr5 deletion strain, a PDR5 over-expressing strain, and the PDR5 wild-type strain using the hydrophilic Pdr5p substrate cycloheximide (CHX) as a model antifungal “drug”. Yeast cells were grown in the presence of a range of CHX (0-0.3 mcg/ml) and P85 (0-10 mg/ml). After incubation for 24hrs at 30°C, the ability of P85 to inhibit Pdr5 efflux activity was examined as a function of cellular growth (as determined by absorbance at 600 nm). Our results indicate that P85 lowers the minimal inhibitory concentration of cycloheximide in both the PDR5 wild-type and PDR5 over-expressing strains, while having no effect on the pdr5 deletion strain. This shows that P85 can increase intracellular concentrations of CHX by inhibiting the Pdr5 transporter. Our results in S. cerevisiae are consistent with reported observations in mammalian cells. Further investigations are being performed to (1) see if pluronics F127, L64, and L81 also inhibit Pdr5 using substrates CHX and itraconazole (ITZ), a hydrophobic antifungal drug, and (2) determine whether solubilization of ITZ in P85 micelles influences its antifungal activity. en
dc.format.extent 2128314 bytes
dc.format.mimetype application/pdf
dc.language.iso en_US
dc.relation.ispartofseries DUCURS 2006;21
dc.subject Yeast fungi en
dc.subject Saccharomyces cerevisiae en
dc.subject Multidrug resistance en
dc.subject Drug resistance in microorganisms en
dc.subject Antifungal agents en
dc.title Inhibition of drug efflux by pluronics in S. cerevisiae en
dc.type Presentation en


Files in this item

This item appears in the following Collection(s)

  • DUCURS [196]
    Poster sessions and presentation from the Drake University Conference on Undergraduate Research in the Sciences held each April at Olmsted Center on the Drake campus.

Show simple item record

Search DSpace


Advanced Search

Browse

My Account